MATINAS BIOPHARMA HOLDINGS, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, value, issued for services for the quarter ending 2021-12-31 was $8.19K, a 95.61% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, value, issued for services for the quarter ending 2021-09-30 was $7.94K, a 49.99% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, value, issued for services for the quarter ending 2021-06-30 was $7.94K, a 49.99% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, value, issued for services for the quarter ending 2021-03-31 was $7.94K, a 95.39% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, value, issued for services for fiscal 2021 was $32.00K, a 91.81% decline from fiscal 2020.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, value, issued for services for fiscal 2020 was $390.64K, a 8.36% increase from fiscal 2019.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, value, issued for services for fiscal 2019 was $360.51K, a 40.15% decline from fiscal 2018.
- MATINAS BIOPHARMA HOLDINGS, INC. stock issued during period, value, issued for services for fiscal 2018 was $602.38K, a 50.45% decline from fiscal 2017.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2021-12-31 | $8.19K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $32.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | $7.94K 10-Q · filed 2022-11-02 | $210.45K derived: sum of 4 quarters · filed 2022-11-02 |
| 2021-06-30 | $7.94K 10-Q · filed 2022-08-11 | $218.39K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $7.94K 10-Q · filed 2022-05-12 | $226.32K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $186.64K derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-11 | $390.64K 10-K/A · filed 2022-03-11 |
| 2020-09-30 | $15.87K 10-Q · filed 2021-11-08 | $262.63K derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $15.87K 10-Q · filed 2021-08-10 | $431.38K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $172.25K 10-Q · filed 2021-05-10 | $474.13K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $58.63K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $360.51K 10-K · filed 2021-03-29 |
| 2019-09-30 | $184.63K 10-Q · filed 2020-11-06 | $369.44K derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $58.63K 10-Q · filed 2020-08-10 | $380.25K derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $58.63K 10-Q · filed 2020-05-11 | $387.32K derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $67.56K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $602.38K 10-K · filed 2020-03-09 |
| 2018-09-30 | $195.44K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $65.69K 10-Q · filed 2019-08-13 | |
| 2018-03-31 | $273.69K 10-Q · filed 2019-05-13 | |
| 2017-12-31 | $1.22M 10-K · filed 2019-04-01 | |
| 2016-12-31 | $300.00K 10-K · filed 2018-03-16 | |
| 2015-12-31 | $238.00K 10-K · filed 2018-03-16 | |
| 2014-12-31 | $152.75K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |